Lexaria Bioscience, a Kelowna, Canada-based company that develops drug delivery platforms, is seeking a listing on the Nasdaq. The company is currently listed on the Over-the-Counter Markets under the ticker "LXRP," as well as the Canadian Securities Exchange under the ticker symbol "LXX."
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Must be a SoFi Plus member at the time a recurring deposit is received into your SoFi Active or Automated investing account to qualify. Bonus calculated on net monthly recurring deposits made via ACH and paid out as Rewards Points. See Rewards Terms of Service. SoFi reserves the right to change or terminate this promotion at any time without notice. See terms and limitations. https://www.sofi.com/sofiplus/invest/#disclaimers
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – LEXX.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Lexaria Bioscience Corp stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
7 of 7
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Lexaria Bioscience Corp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lexaria Bioscience Corp price performance over time
Historical closes compared with the close of $0.8145 from 2025-07-15
1 week (2025-07-11)
-7.54%
1 month (2025-06-18)
-18.55%
3 months (2025-04-17)
-40.98%
6 months (2025-01-17)
-57.13%
1 year (2024-07-18)
-70.49%
2 years (2023-07-18)
2.00%
3 years (2022-07-18)
2.78
5 years (2020-07-17)
9.3495
Lexaria Bioscience Corp financials
Revenue TTM
$525,923
Gross profit TTM
$523,203
Return on assets TTM
-77.6%
Return on equity TTM
-145.55%
Profit margin
0%
Book value
$0.29
Market Capitalization
$15.9 million
TTM: trailing 12 months
Lexaria Bioscience Corp share dividends
We're not expecting Lexaria Bioscience Corp to pay a dividend over the next 12 months.
Lexaria Bioscience Corp's shares were
split on a 1:30 basis on 11 January 2021
. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexaria Bioscience Corp shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Lexaria Bioscience Corp shares which in turn could have impacted Lexaria Bioscience Corp's share price.
Lexaria Bioscience Corp share price volatility
Over the last 12 months, Lexaria Bioscience Corp's shares have ranged in value from as little as $0.7941 up to $4.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience Corp's is 0.939. This would suggest that Lexaria Bioscience Corp's shares are less volatile than average (for this exchange).
To put Lexaria Bioscience Corp's beta into context you can compare it against those of similar companies.
Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp.
Frequently asked questions
null What percentage of Lexaria Bioscience Corp is owned by insiders or institutions? Currently 7.033% of Lexaria Bioscience Corp shares are held by insiders and 6.363% by institutions.How many people work for Lexaria Bioscience Corp? Latest data suggests 7 work at Lexaria Bioscience Corp.When does the fiscal year end for Lexaria Bioscience Corp? Lexaria Bioscience Corp's fiscal year ends in August.Where is Lexaria Bioscience Corp based? Lexaria Bioscience Corp's address is: 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7What is Lexaria Bioscience Corp's ISIN number? Lexaria Bioscience Corp's international securities identification number is: US52886N4060What is Lexaria Bioscience Corp's CUSIP number? Lexaria Bioscience Corp's Committee on Uniform Securities Identification Procedures number is: 52886N406
Looking to invest in AI stocks? Here are some of the best artificial intelligence stocks available, along with tips to better understand AI investments.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
